Significance and Innovation: Verification of 4D dose delivery is important for management of moving tumors. However, it is difficult to implement in clinic due to lack of proper phantom and/or dosimeter which can incorporate patient anatomy a. This study innovatively established a technique for 4D dose delivery verification by using a realistic 4D digital human phantom. Introduction: Respiratory motion introduces uncertainties in lung cancer radiotherapy. While tremendous progresses have been made in treatment techniques such as IMRT, SBRT, etc., verification of the 4D dose delivery for these treatment techniques is limited. Films, EPID, phantom integrated with chamber have been used to verify dose delivery, but these methods did not take into account patient anatomy and respiratory mechanics which affect the precise of dose verification. The objective of our study is to develop an advanced patient-specific 4D dose delivery verification method by using a realistic and flexible 4D digital human phantom. Materials and Methods: The 4D-XCAT phantom [1] incorporating patient anatomy and breathing parameters was generated to evaluate dose delivery with the help of our integrated Matlab Program. In this study, 4D-XCAT images were generated with 10 phases per breathing cycle (period = 5s) and a pseudo tumor (diameter = 3cm) locates in middle right lobe. Maximum intensity projection (MIP) and average intensity projection (AIP) images were generated from the 4D-XCAT.As in clinic, they were used for ITV determination and dose calculation, respectively. 3D conformal technique was used for planning. Real-time 4D dose delivery was simulated by calculating dose deposition in each phase of the 4D-XCATfor each beam. Final 4D dose delivery was obtained by accumulating dose deposition of all beams and all phases using deformable image registration implemented in the VelocityAI software. Fig.1 shows the workflow of 4D dose verification. Dose rate of 600 MU/min was assumed in the simulation. DVHs of target volumes and OARs were compared between the plan and 4D dose delivery. Results: Fig.2 shows the isodose distribution of 4D dose on Phase 0% image (a) and the planned dose on AIP image (b). Fig. 3 illustrates planned and real-time delivered DVHs. For 4D dose delivery, 97.5% of PTV receives prescribed dose. Maximum cord dose, maximum esophagus dose, mean heart dose, and V20Gy of lung were comparable between the planned and delivered dose; the relative difference were 0.3%, 4.0%, 0%, and 2.8%, respectively. These results indicates AIP-based planning was a close representation of the real 4D dose delivery for both target and OARs for regular and reproducible breathing pattern.
